VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $475,231 | -14.7% | 17,660 | -4.6% | 0.04% | -9.8% |
| Q2 2023 | $557,337 | -8.4% | 18,510 | -1.6% | 0.04% | -12.8% |
| Q1 2023 | $608,504 | +17.8% | 18,810 | +4.3% | 0.05% | +14.6% |
| Q4 2022 | $516,740 | +18.0% | 18,030 | -0.7% | 0.04% | +7.9% |
| Q3 2022 | $438,000 | -18.6% | 18,160 | -7.5% | 0.04% | -9.5% |
| Q2 2022 | $538,000 | -30.6% | 19,640 | -2.8% | 0.04% | -20.8% |
| Q1 2022 | $775,000 | +19.4% | 20,215 | -0.3% | 0.05% | +23.3% |
| Q4 2021 | $649,000 | -21.8% | 20,275 | -28.0% | 0.04% | -27.1% |
| Q3 2021 | $830,000 | -7.9% | 28,170 | +6.2% | 0.06% | -9.2% |
| Q2 2021 | $901,000 | +7.4% | 26,525 | +2.7% | 0.06% | -1.5% |
| Q1 2021 | $839,000 | -4.0% | 25,820 | +6.4% | 0.07% | -9.6% |
| Q4 2020 | $874,000 | +21.9% | 24,256 | +32.5% | 0.07% | +9.0% |
| Q3 2020 | $717,000 | +197.5% | 18,311 | +179.1% | 0.07% | +168.0% |
| Q2 2020 | $241,000 | – | 6,561 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |